Anesth Analg 2001;93:287-289
© 2001 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII
Herman G. D. Hendriks, MD*,
Joost M. A. A. van der Maaten, MD*,
Joost de Wolf, MD, PhD ,
Tjalling W. Waterbolk, MD ,
Maarten J. H. Slooff, MD, PhD , and
Jan van der Meer, MD, PhD||||
Departments of *Anesthesiology, Hematology, Thoracic Surgery, Hepatobiliary Surgery and Liver Transplantation, and the ||||Division of Hemostasis, Thrombosis and Rheology, University Hospital, Groningen, The Netherlands
Address correspondence and reprint requests to H. G. D. Hendriks, MD, Groningen University Hospital, Department of Anesthesiology, Hanzeplein 1, PO Box 30.001, 9700 RB Groningen, The Netherlands. Address e-mail to h.g.d.hendriks{at}anest.azg.nl
IMPLICATIONS: The successful treatment with recombinant factor VIIa of a patient experiencing intractable bleeding after cardiac surgery is described.
This article has been cited by other articles:

|
 |

|
 |
 
F. Alsayegh, A. Fakeir, S. Alhumood, K. Abdumalek, H. Matar, I. Samaul, N. Nampoory, H. Kabalawi, and S. A. Mousa
Use of Recombinant Activated Factor VII to Arrest Uncontrolled Bleeding: A Case Series
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2009;
15(2):
225 - 232.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Tanaka, T. Taketomi, F. Szlam, A. Calatzis, and J. H. Levy
Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven(R)) and Fibrinogen (Haemocomplettan(R) P)
Anesth. Analg.,
March 1, 2008;
106(3):
732 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Warren, K. Mandal, V. Hadjianastassiou, L. Knowlton, S. Panesar, K. John, A. Darzi, and T. Athanasiou
Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review
Ann. Thorac. Surg.,
February 1, 2007;
83(2):
707 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jaggers and J. H. Lawson
Coagulopathy and Inflammation in Neonatal Heart Surgery: Mechanisms and Strategies
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
S2360 - S2366.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Romagnoli, S. Bevilacqua, S. Gelsomino, S. Pradella, L. Ghilli, C. Rostagno, G. F. Gensini, and C. Sorbara
Small-Dose Recombinant Activated Factor VII (NovoSeven(R)) in Cardiac Surgery.
Anesth. Analg.,
May 1, 2006;
102(5):
1320 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Levy
Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation
Am. J. Health Syst. Pharm.,
September 15, 2005;
62(18_Supplement_4):
S15 - S19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hyllner, E. Houltz, and A. Jeppsson
Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery
Eur. J. Cardiothorac. Surg.,
August 1, 2005;
28(2):
254 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Raivio, R. Suojaranta-Ylinen, and A. H. Kuitunen
Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac Surgery
Ann. Thorac. Surg.,
July 1, 2005;
80(1):
66 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. DiDomenico, M. G. Massad, J. Kpodonu, R. A. Navarro, and A. S. Geha
Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass
Chest,
May 1, 2005;
127(5):
1828 - 1835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lam and R. P Sims-McCallum
Recombinant Factor VIIa in the Treatment of Non-Hemophiliac Bleeding
Ann. Pharmacother.,
May 1, 2005;
39(5):
885 - 891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mahdy and N. R. Webster
Perioperative systemic haemostatic agents
Br. J. Anaesth.,
December 1, 2004;
93(6):
842 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D Flynn, M. Pajoumand, P. C Camp Jr, M S. Jahania, C. Ramaiah, and W. S Akers
Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation
Ann. Pharmacother.,
October 1, 2004;
38(10):
1639 - 1642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Tobias, J. M. Simsic, S. Weinstein, W. Schechter, V. Kartha, and R. Michler
Recombinant Factor VIIa to Control Excessive Bleeding Following Surgery for Congenital Heart Disease in Pediatric Patients
J Intensive Care Med,
September 1, 2004;
19(5):
270 - 273.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Szabo, S. Ali, and E. M. Camporesi
Intraoperative Recombinant Activated Factor VII for Emergent Epidural Hematoma Evacuation
Anesth. Analg.,
August 1, 2004;
99(2):
595 - 597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. McIlroy and A. J. Silvers
Recombinant Factor VIIa for Life-Threatening Bleeding in High-Risk Cardiac Surgery Despite Full-Dose Aprotinin
Anesth. Analg.,
July 1, 2004;
99(1):
27 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stratmann, A. M. deSilva, E. E. Tseng, J. Hambleton, M. Balea, A. J. Romo, M. J. Mann, N. L. Achorn, W. F. Moskalik, and C. W. Hoopes
Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia
Anesth. Analg.,
June 1, 2004;
98(6):
1635 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stratmann, I. A. Russell, and S. H. Merrick
Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair
Ann. Thorac. Surg.,
December 1, 2003;
76(6):
2094 - 2097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Mindikoglu, A. Anantharaju, J. Villanueva, N. Shah, and D. H. Van Thiel
Pericardiocentesis and Pancreatic Aspiration Needle Biopsy in Coagulopathic and Thrombocytopenic Cirrhotic Patient
Chest,
March 1, 2003;
123(3):
956 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kastrup, C. von Heymann, H. Hotz, W. F. Konertz, S. Ziemer, W. J. Kox, and C. Spies
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
Ann. Thorac. Surg.,
September 1, 2002;
74(3):
910 - 912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Dietrich, M. Spannagl, H. G. D. Hendriks, J. M. A. A. van der Maaten, J. Th. M. de Wolf, and J. van der Meer
Caveat Against the Use of Activated Recombinant Factor VII for Intractable Bleeding in Cardiac Surgery * Response
Anesth. Analg.,
May 1, 2002;
94(5):
1369 - 1371.
[Full Text]
[PDF]
|
 |
|
|